These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4383851)

  • 1. Crystal growth in aqueous suspensions.
    Varney G
    J Pharm Pharmacol; 1967 Dec; 19():Suppl:19S-23S. PubMed ID: 4383851
    [No Abstract]   [Full Text] [Related]  

  • 2. Batch cooling crystallization and pressure filtration of sulphathiazole: the influence of solvent composition.
    Häkkinen A; Pöllänen K; Karjalainen M; Rantanen J; Louhi-Kultanen M; Nyström L
    Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):17-28. PubMed ID: 15283678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study into the prediction of mass transfer of sulphathiazole in aqueous suspension during crystal growth [proceedings].
    Carless JE; Jordan D
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():2P. PubMed ID: 12293
    [No Abstract]   [Full Text] [Related]  

  • 4. Succinylsulfathiazole crystal forms. II: Effect of additives on kinetics of interconversion.
    Ebian AR; Moustafa MA; Khalil SA; Motawi MM
    J Pharm Sci; 1975 Sep; 64(9):1481-4. PubMed ID: 1185561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a preliminary solubility screen to improve crystallization trials: uncoupling crystal condition searches.
    Izaac A; Schall CA; Mueser TC
    Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):833-42. PubMed ID: 16790940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Principles of retardation].
    Hüttenrauch R
    Pharmazie; 1975 Jan; 30(1):3-16. PubMed ID: 1094473
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleation and crystal growth in supersaturated solutions of a model drug.
    Lindfors L; Forssén S; Westergren J; Olsson U
    J Colloid Interface Sci; 2008 Sep; 325(2):404-13. PubMed ID: 18561941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Succinylsulfathiazole crystal forms. III: Crystal growth studies.
    Moustafa MA; Ebian AR; Khalil SA; Motawi MM
    J Pharm Sci; 1975 Sep; 64(9):1485-9. PubMed ID: 1185562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal growth studies involving phase transitions in aqueous drug suspensions.
    Pearson JT; Varney G
    J Pharm Pharmacol; 1969 Dec; 21():Suppl:60S+. PubMed ID: 4391170
    [No Abstract]   [Full Text] [Related]  

  • 10. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
    Sun CC
    Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated crystal growth of sulphathiazole by temperature cycling.
    Carless JE; Foster AA
    J Pharm Pharmacol; 1966 Nov; 18(11):697-708. PubMed ID: 4382045
    [No Abstract]   [Full Text] [Related]  

  • 12. The expulsion of lipophilic drugs from the cores of solid lipid microspheres in diluted suspensions and in concentrates.
    Pietkiewicz J; Sznitowska M; Placzek M
    Int J Pharm; 2006 Mar; 310(1-2):64-71. PubMed ID: 16413712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
    Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
    J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant effects on spray-congealed formulations of sulfaethylthiadiazole--wax.
    John PM; Becker CH
    J Pharm Sci; 1968 Apr; 57(4):584-9. PubMed ID: 5652147
    [No Abstract]   [Full Text] [Related]  

  • 15. Attempts to rationalize protein crystallization using relative crystallizability.
    Zhu DW; Garneau A; Mazumdar M; Zhou M; Xu GJ; Lin SX
    J Struct Biol; 2006 Jun; 154(3):297-302. PubMed ID: 16651006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liberation of active substance from pharmaceutical suspensions I. Effect of surfactants on the active substance dissolving].
    Maher S; Sipos P; Maher S; Szabóné RP; Eros I
    Acta Pharm Hung; 2007; 77(2):142-9. PubMed ID: 17933274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anion effects on electrostatic charging of sterically stabilized, water insoluble drug particles.
    Owen H; Graham S; Werling JO; Carter PW
    Int J Pharm; 2009 Feb; 368(1-2):154-9. PubMed ID: 18996460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of tween 8OR concentration on the particle dimension, rheologic properties and physical stability of chloramphenicol palmitate suspensions].
    Moës A
    J Pharm Belg; 1970; 25(5):409-22. PubMed ID: 5494311
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
    Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
    Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy.
    Tian F; Zeitler JA; Strachan CJ; Saville DJ; Gordon KC; Rades T
    J Pharm Biomed Anal; 2006 Feb; 40(2):271-80. PubMed ID: 16146681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.